A comprehensive industry overview and market perspective are included in the latest study from MarkNtel Advisors titled Global Human Milk Oligosaccharides (HMO) Market. The research provides a detailed overview of the current market state, including market trends and the most recent advancements made globally. In-depth analysis of market size, share, industry trends, forecast, and competitive environment is covered in the report that presents clear picture of the market with relevant statistical data.
The report combines in-depth quantitative analysis with qualitative analysis; it ranges from macro-overviews of the overall market size, industry chain, and market dynamics to micro details of segment markets. This, as a result, provides a thorough overview of the industry under study as well as a profound understanding of all of its important features.
Global Human Milk Oligosaccharides (HMO) Market Definition:
Human Milk Oligosaccharides (HMOs) are a complex group of carbohydrates naturally present in human breast milk. After lactose and lipids, they are the third most abundant solid component in breast milk and are composed of various monosaccharides (simple sugars) linked together in different arrangements.
Request Sample Report- https://www.marknteladvisors.com/query/request-sample/hmo-market.html
Global Human Milk Oligosaccharides (HMO) Market Insights:
The Global Human Milk Oligosaccharides (HMO) Market is projected to grow at around 21.75% CAGR during the forecast period, i.e., 2023-28.
Global Human Milk Oligosaccharides (HMO) Market Driver:
Increasing awareness of the Health Benefits of HMOs and the Rising Demand for Improved Infant Nutrition: There is a growing awareness of the crucial role of nutrition in early childhood development & long-term health outcomes. Since HMOs are naturally occurring components of breast milk, they have been linked to various health benefits, like a healthy gut microbiome, enhanced immunity, and protection against pathogens. This increased focus on infant health & nutrition is fueling the demand for HMOs in infant formula & baby food products worldwide. Numerous studies have cited the potential health benefits of HMOs for infants and created much evidence that supports the positive impact of HMOs on gut health, immune development, and overall well-being, which, in turn, has increased awareness & acceptance of HMOs among healthcare professionals, parents, & consumers. Hence, these factors are expected to drive the Global Human Milk Oligosaccharides (HMO) Market during 2023-28.
Global Human Milk Oligosaccharides (HMO) Market Leading Key Players:
Biosynth Carbosynth, Chr. Hansen Holding A/S, Dextra Laboratories Ltd, DuPont Nutrition & Biosciences, Elicityl S.A., Glycosyn, Inbiose NV, Medolac Laboratories, Nestle Health Science, ROYAL DSM, BASF SE, Abbott Laboratories, GNUBIOTICS Sciences S.A., Dextra Laboratories, Others
Browse Full Report – https://www.marknteladvisors.com/research-library/hmo-market.html
Global Human Milk Oligosaccharides (HMO) Market Segmentation:
Based on Type
– 2’FL- Market Size & Forecast 2018-2028, (USD Million)
– 3’FL- Market Size & Forecast 2018-2028, (USD Million)
– 3’SL- Market Size & Forecast 2018-2028, (USD Million)
– 6’SL- Market Size & Forecast 2018-2028, (USD Million)
Based on Application
– Infant formula- Market Size & Forecast 2018-2028, (USD Million)
– Functional food & beverage- Market Size & Forecast 2018-2028, (USD Million)
– Food supplements- Market Size & Forecast 2018-2028, (USD Million)
– Others-Market Size & Forecast 2018-2028, (USD Million)
Based on Concentration
– Neutral- Market Size & Forecast 2018-2028, (USD Million)
– Acidic- Market Size & Forecast 2018-2028, (USD Million)
– Others– Market Size & Forecast 2018-2028, (USD Million)
Based on Distribution Channel
– Hypermarkets & Supermarkets- Market Size & Forecast 2018-2028, (USD Million)
– Drug store or pharmacy- Market Size & Forecast 2018-2028, (USD Million)
– Mass merchandiser- Market Size & Forecast 2018-2028, (USD Million)
– Departmental Stores- Market Size & Forecast 2018-2028, (USD Million)
– Mono-brand Store-Market Size & Forecast 2018-2028, (USD Million)
– Specialty stores-Market Size & Forecast 2018-2028, (USD Million)
Talk to our Consultant – https://www.marknteladvisors.com/query/talk-to-our-consultant/hmo-market.html
Global Human Milk Oligosaccharides (HMO) Market Geographical Analysis
By Region
– North America
– South America
– Europe
– Asia-Pacific
– The Middle East and Africa
Recent Development of Global Human Milk Oligosaccharides (HMO) Market:
On 18 November 2022, KYOWA HAKKO BIO CO. LTD., a subsidiary of Kirin Holdings Company, Limited, completed the HMO production facility at its Thai subsidiary, THAI KYOWA BIOTECHNOLOGIES CO., LTD.
Request Customization – https://www.marknteladvisors.com/query/request-customization/hmo-market.html
About Us:
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact us:
If you have any questions, our team of trained and professional experts is here to help. You can get in touch with us by calling, sending an email, or using our online contact form.
We will try our best to answer your request as quickly as we can and give you the details you require.
Call: 📞 +1 628 895 8081, +91 120 4278433
Email: 📧 sales@marknteladvisors.com
Visit to know more: 🌐 https://www.marknteladvisors.com/
